Table 1.
RNA | Primer sequence |
---|---|
β-actin | Forward 5′-CCTGTACGGTCCACTGCTTA-3′ |
Reverse 5′-TGGACTTGCATCCAGGTTCA-3′ | |
NEAT1 | Forward 5′-TTACCAGCTTCCTCCTGGTG-3′ |
Reverse 5′-TCTGCTGCGTATGCAAGTCT-3′ | |
MALAT1 | Forward 5′-ATGCGAGTTGTTCTCCGTCT-3′ |
Reverse 5′-TATCTGCGGTTTCCTCAAGC-3′ | |
AR | Forward 5′-CCTGGCTTCCGCAACTTACAC-3′ |
Reverse 5′-GGACTTGTGCATGCGGTACTCA-3′ | |
FST | Forward 5′-CTCTGCCAGTTCATGGAGGA-3′ |
Reverse 5′-TCCTTGCTCAGTTCGGTCTT-3′ | |
IRS-2 | Forward5′-CAAAAGCCATCTCGGTGTAGT-3′ |
Reverse 5′-GCTCTCCGACTACATGAACCTC-3′ |
NEAT1: nuclear enriched abundant transcript 1, MALAT1: metastasis associated lung adenocarcinoma transcript 1, AR: androgen receptor, FST: follistatin and IRS-2: insulin receptor substrate-2.